2023
DOI: 10.3892/ijmm.2023.5225
|View full text |Cite
|
Sign up to set email alerts
|

Deficiency of filamin A in smooth muscle cells protects against hypoxia‑mediated pulmonary hypertension in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…Unfortunately, desmin belonging to type III contractile filaments can be found in different muscle cell types ( Di Conza et al, 2023 ). Likewise, α-SMA is a cytoskeletal protein and presents in smooth-muscle cells and fibroblasts ( Zheng et al, 2023 ). RGS-5 is a protein that activates GTPase proteins and disrupts sphingosine-1-phosphate, endothelin-1, angiotensin II, and PDGF-induced signaling in cultured cells ( Bondjers et al, 2003 ; Cho et al, 2003 ).…”
Section: Pericytes Function and Activitymentioning
confidence: 99%
“…Unfortunately, desmin belonging to type III contractile filaments can be found in different muscle cell types ( Di Conza et al, 2023 ). Likewise, α-SMA is a cytoskeletal protein and presents in smooth-muscle cells and fibroblasts ( Zheng et al, 2023 ). RGS-5 is a protein that activates GTPase proteins and disrupts sphingosine-1-phosphate, endothelin-1, angiotensin II, and PDGF-induced signaling in cultured cells ( Bondjers et al, 2003 ; Cho et al, 2003 ).…”
Section: Pericytes Function and Activitymentioning
confidence: 99%
“…As a highly prevalent cardiopulmonary disorder, pulmonary arterial hypertension (PAH) is characterized with diffused vascular remodeling and pulmonary artery resistance, resulting in subsequent right ventricular dysfunction [ 1 , 2 ]. Dysfunctional pulmonary arterial smooth muscle cells were manifested with abnormal proliferation and migration of PASMCs, together driving progressive remodeling of peripheral pulmonary arteries and augmented right ventricular afterload [ 3 , 4 ]. However, the cellular and molecular mechanism modulating hypoxic PAH remains undefined.…”
Section: Introductionmentioning
confidence: 99%